Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Stereotaxic breast microhistology]

M Macchini1, L Baffoni, S Natale

  • 1Servizio di Diagnostica per Immagini, USL 21 Fermo (AP).

La Radiologia Medica
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI).

ESMO open·2025
Same author

Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2024
Same author

Predictive factors of selective transarterial embolization failure in acute renal bleeding: a single-center experience.

Emergency radiology·2023
Same author

Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey.

ESMO open·2023
Same author

Erratum to 'Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors': [ESMO Open Volume 7, Issue 2, April 2022, 100447].

ESMO open·2022
Same author

Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors.

ESMO open·2022

Microhistologic breast sampling is a reliable alternative to fine-needle aspiration cytology, improving diagnostic accuracy and reducing unnecessary biopsies for breast cancer detection. This method offers better sample adequacy and fewer questionable results.

Area of Science:

  • Radiology
  • Oncology
  • Pathology

Context:

  • Mammography is the primary imaging method for detecting occult breast cancer.
  • Stereotactic-guided aspiration biopsy aids in diagnosing breast lesions.
  • Evaluating alternative biopsy techniques is crucial for improving diagnostic yield.

Purpose:

  • To report the experience with 72 microhistologic breast samplings using fine-needle aspiration cytology.
  • To compare the adequacy and diagnostic accuracy of microhistologic sampling versus fine-needle aspiration cytology.
  • To assess the potential of microhistologic biopsy as an alternative to fine-needle aspiration cytology.

Summary:

  • Adequate cytologic samples were obtained in 88.9% of cases, and microhistologic samples were adequate in 94.4% of cases.

Related Experiment Videos

  • Microhistologic biopsies resulted in fewer questionable diagnoses compared to fine-needle aspiration cytology.
  • This technique avoided 50% of inadequate cytologic samplings, with overall inadequate samples at 11.1% for cytology and 5.6% for microhistology.

    • Impact:

    • Microhistologic biopsy is a reliable and well-tolerated procedure.
    • It offers a valuable alternative to fine-needle aspiration cytology for breast cancer diagnosis.
    • Reduced questionable results can lead to fewer unnecessary invasive procedures.